The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.

By Mandeep R. Mehra, C. Canter, M. Hannan, M. Semigran, P. Uber, D. Baran, L. Danziger-Isakov, J. Kirklin, R. Kirk, S. Kushwaha and 6 more. The Journal of Heart and Lung Transplantation, 2016

1,265 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Surgery

View Paper: https://www.semanticscholar.org/paper/dbdf07818282022c13a20e620a1073e560fda80f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Khush

Citations in the corpus

• The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. (2017, background): “Compared with advanced heart failure before transplant, heart transplantation in appropriately selected candidates is associated with dramatic improvements in survival, functional status, and quality of life.(6) Functional status remained favorable at 1 to 3 years after transplant, (eSlide H(a) 83),”
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, neutral): “In patients with cancer requiring heart transplantation, a close collaboration with oncology specialists should occur to stratify each patient as to their risk of tumour recurrence.(616) Table 13.”
• Myocarditis in Patients Treated With Immune Checkpoint Inhibitors (2018, neutral): “For example, active malignancy is an absolute contraindication for cardiac transplantation (33), and although active malignancy does not preclude temporary mechanical circulatory support for cardiogenic shock, it does influence candidacy for subsequent durable mechanical circulatory support.”